Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC

ASCO 2026: Latest updates in mRCC

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma

ASCO 2026: Breast cancer overview

Bezuclastinib sunitinib combo shows promise in second-line GIST treatment

mRNA-4359 plus pembrolizumab shows high response rates and robust T-cell activation in melanoma

Is radiotherapy a back up plan after neoadjuvant chemo-immunotherapy in perioperative lung cancer management?

Part 4: Clinical decision making - Interpretation of next generation sequencing results

Screen-detectable cancers account for majority of early-onset cancer cases under age 50

Machine learning models improve prediction of immunotherapy outcomes across multiple cancer types